The body’s immune system runs on a circadian rhythm, meaning the timing of treatments like immunotherapy or vaccines can influence how well they work. Studies in humans and animals show that morning administration often leads to stronger immune responses and better survival outcomes, a finding now being explored for canine cancer care.

Dr. Jeffrey Bryan of the University of Missouri explains how the Elias Cancer Immunotherapy works, what the response rates look like, and the types of canine cancers it may treat. He also addresses eligibility, access, and potential side effects.

Lymphoma is one of the most common cancers diagnosed in dogs, but advances in veterinary oncology are giving families new hope.

Vaccines can sometimes trigger cancer—but they also prevent and treat it. Explore the science behind cancer vaccines in pets, from rare injection-site sarcomas to promising new immunotherapies for dogs and cats.

This webinar shared surprising findings from 2024, including hemangiosarcoma treatments, osteosarcoma treatment without surgery, and more.